Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Amazon.com, Inc.
WARNING LETTER
•Amazon.com, Inc.•August 18, 2023

Amazon.com, Inc. – FDA Warning Letter, Aug 18, 2023

Record Details

The FDA issued a Warning Letter to Amazon concerning the distribution of unapproved new drugs intended to treat molluscum contagiosum on www.amazon.com. The FDA purchased "Naturasil Molluscum Treatment Kit," "Conzerol 2 Step Treatment for Molluscum Contagiosum," "ZymaDerm for Molluscum," and "HealthyDerm Molluscum Contagiosum Treatment" via Amazon's Fulfillment by Amazon service.

These products are considered drugs under section 201(g)(1) of the FD&C Act due to their intended use for treating molluscum contagiosum, a condition not amenable to self-diagnosis or treatment, and for which no legally marketed OTC drugs exist. The FDA cited claims on product labels and inserts establishing their drug intended use, such as "Molluscum Treatment Kit," "Antiviral Molluscum Soap," and "Homeopathic Treatment for Molluscum Contagiosum."

The products are deemed "new drugs" under section 201(p) of the FD&C Act because they are not generally recognized as safe and effective for their stated uses and lack FDA approval. Introducing or delivering these unapproved new drugs into interstate commerce violates sections 301(d) and 505(a) of the FD&C Act. The FDA expressed particular concern as these products are marketed for children, potentially delaying proper diagnosis and treatment of a

Company
Amazon.com, Inc.
Inspection date
August 18, 2023
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Jill P. Furman (Director)
View Company Profile

ID · bd136bdd-91a3-47e0-88de-57ec971708d6

Violation Codes4
21.U.S.C. 355(a)21 U.S.C. 331(d)21 U.S.C. 321(g)(1)21 U.S.C. 321(p)

Full citation text and observation details available on the Dashboard.

Other documents for Amazon.com, Inc.
  • WARNING_LETTER - 2025-04-29April 29, 2025
  • WARNING_LETTER - 2025-03-03March 3, 2025
  • WARNING_LETTER - 2024-07-30July 30, 2024
  • WARNING_LETTER - 2023-12-20December 20, 2023
  • WARNING_LETTER - 2023-11-14November 14, 2023

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Amazon.com, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.